The independent source for health policy research, polling, and news.
The Centers for Medicare & Medicaid Services launched this month the “What’s Covered” app, designed to provide yes-or-no answers about what services are covered under traditional Medicare. KHN took it for a test drive with real consumers.
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
Inspired by Los Angeles teachers, who were promised 300 more school nurses after striking last month, unions in Denver, Oakland, Calif., and beyond are demanding more school nurses or better compensation for them.
Health officials and doctors treating patients with HIV welcome the funding push, but warn that the strategies that work in progressive cities don’t necessarily translate to rural areas.
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.
For dozens of hours each week, Dawn Wilcox scours the internet for news stories of women killed by men for a public list called Women Count USA.
Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that’s not medically necessary to pay for.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
Only a small percentage of people who survived an opioid overdose received in the next year some form of drug abuse treatment, according to an analysis of West Virginia Medicaid claims data. Experts say the findings underscore a national disconnect.
The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.
A significant portion of syphilis transmission in heterosexuals occurs among people who use drugs, particularly methamphetamine, a new report shows. Public health officials warn that you can’t treat one problem without addressing the other.
As calls for “Medicare-for-all” grow louder among Democrats in Congress, Democratic governors and mayors have been pushing ahead with urgency to corral medical costs and bring health care to those who remain uninsured.
Utah’s proposal to limit federal and state funding on Medicaid is a radical change. Anti-poverty advocates are concerned that caps could limit how many people are enrolled and restrict services. They also worry other states would adopt a similar plan.
A new study examines how seniors with deteriorating strength and other physical functions deal with such challenges as taking a shower or getting dressed in the morning.
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
In Texas, many people have a right to mediation of medical bills. But the concept can be off-putting, and patients often think they need a lawyer, which isn’t the case.
KHN columnist Judith Graham speaks with Sarah Szanton, director of the Center for Innovative Care in Aging at Johns Hopkins School of Nursing, about helping people age with independence.
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
